Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
about
Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer modelarrayMap: a reference resource for genomic copy number imbalances in human malignanciesMolecular profiling of patient-derived breast cancer xenograftsDART: Denoising Algorithm based on Relevance network Topology improves molecular pathway activity inferenceGREB1 functions as a growth promoter and is modulated by IL6/STAT3 in breast cancerZNF703 gene amplification at 8p12 specifies luminal B breast cancerZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epitheliumSin3b interacts with Myc and decreases Myc levelsMethylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancersGenome analysis identifies the p15ink4b tumor suppressor as a direct target of the ZNF217/CoREST complexFAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasisDifferential oestrogen receptor binding is associated with clinical outcome in breast cancerGenomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristicsComprehensive molecular portraits of human breast tumoursComplex landscapes of somatic rearrangement in human breast cancer genomes.The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progressionIntegrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancerAmplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancerA sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genomeMicroRNA expression profiling of human breast cancer identifies new markers of tumor subtypeA collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCo-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesisCancer Hallmarks, Biomarkers and Breast Cancer Molecular SubtypesFbxw7 Tumor Suppressor: A Vital Regulator Contributes to Human TumorigenesisBladder Cancer Stem-Like Cells: Their Origin and Therapeutic PerspectivesTargeting RTK Signaling Pathways in CancerIntegrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potentialPatterns of Chromosomal Aberrations in Solid TumorsThe consequences of chromosomal aneuploidy on the transcriptome of cancer cellsFunctional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancersNew genes contribute to genetic and phenotypic novelties in human evolutionRb suppresses collective invasion, circulation and metastasis of breast cancer cells in CD44-dependent manner8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosisFGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancerRSF1 and not cyclin D1 gene amplification may predict lack of benefit from adjuvant tamoxifen in high-risk pre-menopausal women in the MA.12 randomized clinical trial.Prognostic value of FGFR gene amplification in patients with different types of cancer: a systematic review and meta-analysis.Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breastBrk is coamplified with ErbB2 to promote proliferation in breast cancerThe UCSC Cancer Genomics Browser
P2860
Q21090788-7D3B0D97-22DF-4DE6-A3DB-2EA0E55A456AQ21134582-5B3B7074-968D-4CBE-81C4-905D8CAAAF60Q21195204-7ACAE7FB-67A6-4A23-8FAE-8822354F6379Q21284334-45A3AF79-D4B4-4F0E-8E03-7D407BB9DD88Q21560759-8C0CEA01-10A6-494B-94D1-344EC828375EQ24293333-348F7B8A-69CE-4DDE-9A66-F6D92CFC7D06Q24293658-94FED349-0079-417B-8A3E-182D129DD6BFQ24299671-8F6859C0-ECF6-4ACE-970D-76277D0AF8EAQ24309483-B8E97E01-B417-43BF-941E-E13FCE9D7142Q24313142-B7F630BB-B511-49A6-B791-9C63D6B2EB3AQ24313524-42140042-B8B7-4DFB-B464-E2CA4023026AQ24316768-1C6D261A-B7F5-4098-B340-3C1ECFA97AEDQ24595511-90FA04C8-0DAA-4810-A798-7577890F668CQ24595882-24A9098C-CCED-409E-B130-E614B861E947Q24630844-6A1D2561-CBA8-4F60-8D73-0C00ECEB5B55Q24631412-880C3D0C-91C8-4C54-AD1C-8CD768167982Q24632821-6DA7417E-A755-48C6-90F6-E64ACF8D8947Q24633201-D9C258D8-CDCC-4890-984B-A3C89BBF4597Q24644185-C742B7D9-E622-458D-9624-585964737EBCQ24644321-54A9A8EA-073E-4D42-BDB9-AEB2DBBA9929Q24646090-F31695BF-046E-4FB0-B72B-06A6E0ADD8D2Q24647928-CC6139AC-98C4-4492-83A0-1315D7828EC6Q24655172-770E0D10-8113-4DC3-8FE2-BC2B3DFBA486Q26743510-A26C969C-A8D0-4733-998D-3396D13504D7Q26765153-A327E02E-D0FB-4CCE-9767-5FC988C36B66Q26771263-05B88B4E-E71F-40A3-A820-37552F861003Q26781278-458C5771-2EB7-4783-8E27-70326D803E56Q26782613-64F724B6-62B7-4529-947F-44F09C75C782Q26786127-D28968F0-5895-4C49-9894-A6D64D54218EQ26995532-D3E97231-A058-45AC-B339-FA8FACECEEEDQ26998955-335956DE-791F-4EA0-BE02-9FA4210FA56AQ27026809-66ACC882-0E3A-498C-B462-585054523815Q27301808-652F215A-3AA1-4896-8675-810F4F98A86CQ27340316-91CEF9A9-FD76-4B33-9E4D-5076B648AC5CQ27851554-DDC1C437-0EB3-4A8A-B263-1B40E99DBDBBQ27852757-07A30A78-A9AD-462F-9FF2-1EEB59AB759FQ27853061-4F143FD6-19EE-4337-8553-94F455D5E90BQ28083103-E7E9B597-047F-42B6-A06E-B403C7BD871FQ28115616-BB5F2216-9DCD-4174-BCA5-E0310E55C03BQ28239848-C9F1DDAD-7390-4FCB-BE52-ACABB789B565
P2860
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
@ast
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
@en
type
label
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
@ast
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
@en
prefLabel
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
@ast
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
@en
P2093
P3181
P1433
P1476
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
@en
P2093
Albertson DG
Esserman L
Fridlyand J
P304
P3181
P356
10.1016/J.CCR.2006.10.009
P407
P577
2006-12-01T00:00:00Z